Scinai Immunotherapeutics Ltd.
SCNI
$1.13
-$0.14-11.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.07M | -2.07M | -2.23M | -2.32M | 3.11M |
| Total Depreciation and Amortization | 352.00K | 352.00K | 499.00K | 496.00K | 145.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 151.50K | 151.50K | 180.00K | 371.00K | -1.12M |
| Change in Net Operating Assets | 276.00K | 276.00K | 475.00K | -303.00K | -4.35M |
| Cash from Operations | -1.29M | -1.29M | -1.08M | -1.76M | -2.22M |
| Capital Expenditure | -6.00K | -6.00K | 0.00 | -6.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -6.00K | 0.00 | -6.00K | -20.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 790.50K | 790.50K | 0.00 | 1.43M | 1.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 2.00M | -1.42M | -- |
| Cash from Financing | 790.50K | 790.50K | 2.00M | 12.00K | 1.09M |
| Foreign Exchange rate Adjustments | 21.00K | 21.00K | 2.00K | -121.00K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 121.00K | -- |
| Net Change in Cash | -482.00K | -482.00K | 926.00K | -1.75M | -1.15M |